title: Cardiac insufficiency in infants.
abstract: Cardiac failures in young children have shown an enormous trudge in recent past. The reason being medical community has laid more stress on cardiac insufficiency management on adult patients and has conducted a large amount of research on the management of heart failure in adults, which has given rise to significant changes in management in the last decade. However, there are far fewer studies in children and those which do exist are often small, retrospective and use a diverse range of measures to assess efficacy. Current research is being focused worldwide to deal with this life threatening problem of young patients. The present review shall enlighten the above focus of the research and will discuss latest developments in therapeutic advances like paediatric use of ace inhibitors, beta blockers in young patients for the efficient management of cardiac insufficiency.
authors.affiliation: Department of Cardiology, Xuzhou Children's Hospital, Xuzhou, China.
authors.forename: Chunli
authors.initials: C
authors.lastname: Li
authors.affiliation: Department of Cardiology, Xuzhou Children's Hospital, Xuzhou, China - mingyufu1@gmail.com.
authors.forename: Xinjiang
authors.initials: X
authors.lastname: An
authors.affiliation: Department of Cardiology, Xuzhou Children's Hospital, Xuzhou, China.
authors.forename: Ling
authors.initials: L
authors.lastname: Niu
authors.affiliation: Department of Cardiology, Xuzhou Children's Hospital, Xuzhou, China.
authors.forename: Haining
authors.initials: H
authors.lastname: Zhang
authors.affiliation: Department of Cardiology, Xuzhou Children's Hospital, Xuzhou, China.
authors.forename: Zhenzhou
authors.initials: Z
authors.lastname: Wang
authors.affiliation: Department of Cardiology, Xuzhou Children's Hospital, Xuzhou, China.
authors.forename: Mingyu
authors.initials: M
authors.lastname: Fu
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000367:Age Factors; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D035843:Biomedical Research / Q000379:methods*; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007223:Infant; D012107:Research Design
chemical_list: D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002317:Cardiovascular Agents